News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
138,061 Results
Type
Article (4518)
Company Profile (8)
Press Release (133535)
Section
Business (42157)
Career Advice (62)
Deals (8176)
Drug Delivery (14)
Drug Development (16325)
Employer Resources (4)
FDA (3920)
Job Trends (2487)
News (73025)
Policy (8815)
Tag
Academia (284)
Alliances (12862)
ALS (26)
Alzheimer's disease (207)
Antibody-drug conjugate (ADC) (18)
Approvals (3963)
Artificial intelligence (24)
Bankruptcy (49)
Best Places to Work (2133)
Biosimilars (45)
Breast cancer (30)
Cancer (341)
Career advice (58)
Cell therapy (38)
Clinical research (13929)
Collaboration (131)
COVID-19 (532)
C-suite (24)
Data (311)
Diabetes (27)
Diagnostics (1046)
Drug discovery (22)
Drug pricing (26)
Earnings (18304)
Events (15069)
Executive appointments (79)
FDA (4102)
Funding (109)
Gene therapy (34)
GLP-1 (139)
Government (1689)
Healthcare (2963)
Infectious disease (553)
Inflammatory bowel disease (38)
Intellectual property (18)
IPO (3450)
Job creations (503)
Job search strategy (57)
Layoffs (30)
Legal (1544)
Liver cancer (21)
Lung cancer (58)
Lymphoma (22)
Manufacturing (41)
Medical device (2669)
Medtech (2670)
Mergers & acquisitions (4803)
Metabolic disorders (87)
Neuroscience (283)
NextGen: Class of 2025 (625)
Non-profit (535)
Northern California (219)
Obesity (49)
Patents (39)
People (9549)
Phase I (3300)
Phase II (5673)
Phase III (5792)
Pipeline (168)
Postmarket research (608)
Preclinical (1134)
Prostate cancer (21)
Radiopharmaceuticals (61)
Rare diseases (47)
Real estate (1012)
Regulatory (5980)
Research institute (295)
Series A (23)
Southern California (222)
Startups (643)
United States (2357)
Vaccines (104)
Weight loss (30)
Date
Today (12)
Last 7 days (135)
Last 30 days (429)
Last 365 days (6239)
2025 (854)
2024 (6508)
2023 (7707)
2022 (14143)
2021 (14340)
2020 (12927)
2019 (9107)
2018 (7175)
2017 (7148)
2016 (6301)
2015 (7537)
2014 (5642)
2013 (4605)
2012 (4831)
2011 (4895)
2010 (4643)
Location
Africa (155)
Asia (22695)
Australia (3001)
California (520)
Canada (966)
China (154)
Connecticut (32)
Delaware (17)
Europe (20720)
Florida (91)
Georgia (34)
Illinois (38)
Indiana (39)
Japan (75)
Maryland (115)
Massachusetts (465)
Minnesota (37)
New Jersey (303)
New York (214)
North Carolina (96)
Northern California (219)
Pennsylvania (139)
South America (216)
Southern California (222)
Texas (79)
Virginia (19)
Washington State (40)
138,061 Results for "boehringer ingelheim canada ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.
January 10, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Boehringer Ingelheim’s Lung Fibrosis Drug Scores Second Late-Stage Win
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary fibrosis—nearly six months after achieving a similar feat in idiopathic pulmonary fibrosis. Boehringer plans to submit for FDA and other global approvals in both indications.
February 10, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Boehringer Canada Announces Availability of SPEVIGO® for expanded indication in Canada
February 6, 2025
·
7 min read
Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats
Boehringer Ingelheim announced that SENVELGO™, a revolutionary new treatment for cats with diabetes, has been approved by Health Canada, marking a significant step in the treatment of feline diabetes in Canada.
May 7, 2024
·
3 min read
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug price negotiation program.
January 17, 2025
·
2 min read
·
Tristan Manalac
Business
PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim
PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.
June 3, 2024
·
2 min read
Press Releases
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
February 26, 2025
·
2 min read
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Press Releases
Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza
February 24, 2025
·
5 min read
Biosimilars
Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount
In a bid to take advantage of Humira’s slow loss of market share, Boehringer Ingelheim is offering its biosimilar at a 92% discount exclusively to patients who buy the product on GoodRx.
July 19, 2024
·
2 min read
·
Tristan Manalac
1 of 13,807
Next
